OXFORD BIOTHERAPEUTICS
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAPยฎ (Oxford Genome Anatomy Project) platform. OGAPยฎ is one of the worldโs largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.
OXFORD BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Health Care Health Diagnostics Therapeutics
Founded:
2004-01-01
Address:
Oxton, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxbt.co.uk
Total Employee:
11+
Status:
Active
Contact:
44 1235 861 770
Email Addresses:
[email protected]
Total Funding:
33.22 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS AppRiver Namesco DNS Namesco
Similar Organizations
Candel Therapeutics
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aptamer Group
Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.
Centre for Sight
Centre for Sight provides eye care services, from basic diagnostic and therapeutic services to complex operative procedures.
Clinical Genomics Technologies
Clinical Genomics develops innovative products for colorectal cancer diagnosis.
DRO Biosystems
DRO Biosystems develops technologies for the manufacture and purification of therapeutic molecules produced in living organisms.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
miDiagnostics
miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
Nanomix
Nanลmix has developed a mobile, POC diagnostic system to provide rapid and actionable diagnostics in hospital and pre-hospital environments.
Nouscom
Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
NOVACYT
NOVACYT develops cellular diagnostics with a growing portfolio of cancer and infectious disease products and services.
Orphazyme
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.
Oxford BioMedica
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Roche Diagnostics
Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon.
Current Advisors List
Current Employees Featured
Founder
Investors List
Renaissance Capital Partners
Renaissance Capital Partners investment in Funding Round - Oxford BioTherapeutics
Calculus Capital
Calculus Capital investment in Venture Round - Oxford BioTherapeutics
Renaissance Capital Partners
Renaissance Capital Partners investment in Series A - Oxford BioTherapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Oxford BioTherapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Oxford BioTherapeutics
South East Growth Fund & Management
South East Growth Fund & Management investment in Venture Round - Oxford BioTherapeutics
Oxford Capital Partners
Oxford Capital Partners investment in Venture Round - Oxford BioTherapeutics
South East Growth Fund & Management
South East Growth Fund & Management investment in Venture Round - Oxford BioTherapeutics
Oxford Capital Partners
Oxford Capital Partners investment in Venture Round - Oxford BioTherapeutics
Catapult Ventures
Catapult Ventures investment in Venture Round - Oxford BioTherapeutics
Official Site Inspections
http://www.oxbt.co.uk
- Host name: fwd0.hosts.co.uk
- IP address: 85.233.160.22
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
